NASDAQ:ACHC

Acadia Healthcare Stock Forecast, Price & News

$61.56
-1.57 (-2.49 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$61.00
$62.48
50-Day Range
$58.87
$67.80
52-Week Range
$23.63
$68.00
Volume832,100 shs
Average Volume522,857 shs
Market Capitalization$5.52 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.57
30 days | 90 days | 365 days | Advanced Chart
Receive ACHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Acadia Healthcare and its competitors with MarketBeat's FREE daily newsletter.


Acadia Healthcare logo

About Acadia Healthcare

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of December 31, 2020, it operated a network of 572 behavioral healthcare facilities with approximately 18,100 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.05 out of 5 stars

Medical Sector

1076th out of 2,100 stocks

Specialty Outpatient Clinics, Not Elsewhere Classified Industry

5th out of 8 stocks

Analyst Opinion: 1.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions

Is Acadia Healthcare a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 5 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Acadia Healthcare stock.
View analyst ratings for Acadia Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than Acadia Healthcare?

Wall Street analysts have given Acadia Healthcare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Acadia Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Acadia Healthcare's next earnings date?

Acadia Healthcare is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Acadia Healthcare
.

How were Acadia Healthcare's earnings last quarter?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) posted its quarterly earnings data on Wednesday, April, 28th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.45 by $0.02. The business had revenue of $551.20 million for the quarter, compared to the consensus estimate of $542.76 million. Acadia Healthcare had a positive trailing twelve-month return on equity of 10.82% and a negative net margin of 26.00%.
View Acadia Healthcare's earnings history
.

How has Acadia Healthcare's stock price been impacted by COVID-19 (Coronavirus)?

Acadia Healthcare's stock was trading at $23.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACHC shares have increased by 163.1% and is now trading at $61.56.
View which stocks have been most impacted by COVID-19
.

What guidance has Acadia Healthcare issued on next quarter's earnings?

Acadia Healthcare updated its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share guidance of 2.300-2.550 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.360. The company issued revenue guidance of $2.24 billion-$2.29 billion, compared to the consensus revenue estimate of $2.26 billion.

What price target have analysts set for ACHC?

9 analysts have issued 12 month target prices for Acadia Healthcare's stock. Their forecasts range from $42.00 to $73.00. On average, they anticipate Acadia Healthcare's share price to reach $59.80 in the next twelve months. This suggests that the stock has a possible downside of 2.9%.
View analysts' price targets for Acadia Healthcare
or view top-rated stocks among Wall Street analysts.

Who are Acadia Healthcare's key executives?

Acadia Healthcare's management team includes the following people:
  • Ms. Debra K. Osteen, CEO & Director (Age 65, Pay $2.34M)
  • Mr. David M. Duckworth, Chief Financial Officer (Age 41, Pay $1.49M)
  • Mr. John S. Hollinsworth, Exec. VP of Operations (Age 57, Pay $1.39M)
  • Mr. Christopher L. Howard, Exec. VP, Gen. Counsel & Sec. (Age 54, Pay $1.35M)
  • Mr. Laurence L. Harrod, Exec. VP of Fin. (Age 64, Pay $1.72M)
  • Gretchen Hommrich, Director of Investor Relations
  • Dr. Anne Kelly B.S.N., Ed.D., Chief Quality & Compliance Officer
  • Ms. Isa Diaz, Sr. VP of Strategic Affairs
  • Dr. Michael Genovese J.D., M.D., Chief Medical Officer
  • Dr. Catherine McDonald M.D., Pres of the Clinic - Acadia Vermilion Hospital

What is Debra K. Osteen's approval rating as Acadia Healthcare's CEO?

41 employees have rated Acadia Healthcare CEO Debra K. Osteen on Glassdoor.com. Debra K. Osteen has an approval rating of 36% among Acadia Healthcare's employees. This puts Debra K. Osteen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Acadia Healthcare's key competitors?

What other stocks do shareholders of Acadia Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acadia Healthcare investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), American Airlines Group (AAL), Archer-Daniels-Midland (ADM), (APA), Athabasca Oil (ATH), Aegean Marine Petroleum Network (ANW), Broadcom (AVGO), Exxon Mobil (XOM) and Colfax (CFX).

What is Acadia Healthcare's stock symbol?

Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."

Who are Acadia Healthcare's major shareholders?

Acadia Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (12.02%), BlackRock Inc. (8.74%), Dimensional Fund Advisors LP (6.74%), William Blair Investment Management LLC (5.35%), JPMorgan Chase & Co. (4.49%) and P2 Capital Partners LLC (2.82%). Company insiders that own Acadia Healthcare stock include Debra K Osteen and Reeve B Waud.
View institutional ownership trends for Acadia Healthcare
.

Which institutional investors are selling Acadia Healthcare stock?

ACHC stock was sold by a variety of institutional investors in the last quarter, including P2 Capital Partners LLC, Abrams Bison Investments LLC, Goldman Sachs Group Inc., Millennium Management LLC, Bank of New York Mellon Corp, Prudential Financial Inc., Point72 Asset Management L.P., and LSV Asset Management.
View insider buying and selling activity for Acadia Healthcare
or view top insider-selling stocks.

Which institutional investors are buying Acadia Healthcare stock?

ACHC stock was acquired by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Viking Global Investors LP, Polar Capital Holdings Plc, Price T Rowe Associates Inc. MD, Loomis Sayles & Co. L P, JPMorgan Chase & Co., BlackRock Inc., and Woodline Partners LP.
View insider buying and selling activity for Acadia Healthcare
or or view top insider-buying stocks.

How do I buy shares of Acadia Healthcare?

Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acadia Healthcare's stock price today?

One share of ACHC stock can currently be purchased for approximately $61.56.

How much money does Acadia Healthcare make?

Acadia Healthcare has a market capitalization of $5.52 billion and generates $2.09 billion in revenue each year. The company earns $-672,130,000.00 in net income (profit) each year or $2.78 on an earnings per share basis.

How many employees does Acadia Healthcare have?

Acadia Healthcare employs 42,200 workers across the globe.

What is Acadia Healthcare's official website?

The official website for Acadia Healthcare is www.acadiahealthcare.com.

Where are Acadia Healthcare's headquarters?

Acadia Healthcare is headquartered at 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067.

How can I contact Acadia Healthcare?

Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.


This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.